- Home
- RVPH vs ALTS Comparison
RVPH vs ALTS Comparison
Compare RVPH & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- ALTS
- Stock Information
- Founded
- RVPH 2006
- ALTS 1976
- Country
- RVPH United States
- ALTS United States
- Employees
- RVPH N/A
- ALTS N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- ALTS
- Sector
- RVPH Health Care
- ALTS
- Exchange
- RVPH Nasdaq
- ALTS NYSE
- Market Cap
- RVPH 88.0M
- ALTS 72.7M
- IPO Year
- RVPH N/A
- ALTS N/A
- Fundamental
- Price
- RVPH $1.76
- ALTS $6.58
- Analyst Decision
- RVPH Strong Buy
- ALTS
- Analyst Count
- RVPH 5
- ALTS 0
- Target Price
- RVPH $11.40
- ALTS N/A
- AVG Volume (30 Days)
- RVPH 1.5M
- ALTS 228.8K
- Earning Date
- RVPH 11-14-2024
- ALTS 04-07-2025
- Dividend Yield
- RVPH N/A
- ALTS N/A
- EPS Growth
- RVPH N/A
- ALTS N/A
- EPS
- RVPH N/A
- ALTS N/A
- Revenue
- RVPH N/A
- ALTS $7,110,000.00
- Revenue This Year
- RVPH N/A
- ALTS N/A
- Revenue Next Year
- RVPH N/A
- ALTS N/A
- P/E Ratio
- RVPH N/A
- ALTS N/A
- Revenue Growth
- RVPH N/A
- ALTS N/A
- 52 Week Low
- RVPH $0.60
- ALTS $0.78
- 52 Week High
- RVPH $4.59
- ALTS $7.09
- Technical
- Relative Strength Index (RSI)
- RVPH 43.34
- ALTS 57.39
- Support Level
- RVPH $1.97
- ALTS $4.60
- Resistance Level
- RVPH $2.14
- ALTS $6.36
- Average True Range (ATR)
- RVPH 0.15
- ALTS 0.60
- MACD
- RVPH -0.03
- ALTS -0.03
- Stochastic Oscillator
- RVPH 15.96
- ALTS 79.90
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.